Targeting cancer: a NOvel way.
A nitric oxide (NO) prodrug has been shown to selectively kill NO-sensitive leukemia cells, leaving healthy cells unharmed.
Biomedical subjects
Publications and source records attributed to Martina Habeck.
A nitric oxide (NO) prodrug has been shown to selectively kill NO-sensitive leukemia cells, leaving healthy cells unharmed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A new compound has been shown to interfere with quroum sensing in Pseudomonas aeruginosa, which could lead to a new class of antibiotics.
Scientists are trying to create hormone analogues that will work more effectively with defective receptors than natural hormones do.
A drug has entered clinical trials that contains a recombinant version of the main extract from mistletoe, adn holds promise for cancer patients.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.